MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA Study

Magda Tsolaki, Vasileios Papaliagkas*, Giovanni Frisoni, Roy Jones, Jacques Touchon, Luiza Spiru, Bruno Vellas, Frans Verhey, Bengt Winblad, Pieter Jelle Visser

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1407-1413
JournalCurrent Alzheimer Research
Volume13
Issue number12
DOIs
Publication statusPublished - 2016

Keywords

  • Alzheimer's disease
  • anticholinergic drugs
  • co-morbidity
  • medication
  • mild cognitive impairment

Cite this